Truveta’s Post

View organization page for Truveta, graphic

68,010 followers

Recently, Truveta Research released the latest installment of their GLP-1 RA monitoring report. The report shows that overall prescription rates and first-time prescriptions for medications that are now commonly being prescribed for weight loss, like semaglutide, tirzepatide, and others, aren't showing any signs of slowing down. Use your LinkedIn credentials to view the report in Truveta Studio: https://tr.vet/4eC6IXD #Semaglutide #Tirzepatide #Liraglutide #GLP1 #GLP1Data #GLP1PrescriptionTrends #PrescriptionTrends #PrescriptionData #HealthData #HealthTech #HealthcareData #HealthcareAI #HealthcareInnovation #AI #Innovation #LLM #MedicalResearch #MedicalTechnology #MedTech #WeightLoss #WeightLossDrugs

Truveta Studio: GLP-1 RA prescription trends monitoring report

Truveta Studio: GLP-1 RA prescription trends monitoring report

login.truveta.com

USA and international Research .

Chief Executive Officer at USA and International Research Inc.

2w

Interesting insights from Truveta Research on the sustained prescription rates for GLP-1 RA medications like semaglutide and tirzepatide! Looking forward to diving into the latest report.

Like
Reply

To view or add a comment, sign in

Explore topics